Sigyn Therapeutics

SIGY

OTCN/A

Income Statement

Total Revenue$-9.18K

Gross Profit$-5.06K

Operating Income$-1.37M

EBITDA$-1.41M

EBIT$-1.37M

Pre-tax Income$-3.25M

Net Income$-1.68M

Net Cash$856K

Cash Equivalent$42.2K

Total Debt$259.33K

Net Debt$-596.67K

Book Value$49.59K

Net Cash Per Share0.53

Book Value Per Share0.00

Return on Equity (ROE)-1269.76%

Return on Assets (ROA)-1288.35%

Return on Invested Capital (ROI)-203.85%

Net Profit Margin-2145.64%

Current Ratio0.03

Quick Ratio0.02

Long-Term Debt / Equityundefined